Increase of Serum Ferritin Levels During HCV Triple Therapy With Telaprevir, PEG-Interferon ALPHA-2A and Ribavirin Predicts Rrvr

被引：0
|
作者：
Zopf, Steffen
Janisch, Florian
Siebler, Juergen
Neurath, Markus F.
Janisch, Hans-Dieter
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S980 / S980
页数：1
相关论文
共 50 条
  • [31] Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1
    Nishida, Naoshi
    Iwanishi, Mina
    Minami, Tomohiro
    Chishina, Hirokazu
    Arizumi, Tadaaki
    Takita, Masahiro
    Kitai, Satoshi
    Yada, Norihisa
    Ida, Hiroshi
    Hagiwara, Satoru
    Minami, Yasunori
    Ueshima, Kazuomi
    Sakurai, Toshiharu
    Kitano, Masayuki
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2015, 33 (06) : 708 - 714
  • [32] Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin
    Vilar, Fernando Crivelenti
    de Castro, Gleusa
    Moya, Maria Janete
    Candolo Martinelli, Ana de Lourdes
    De Santis, Gil Cunha
    Nunes da Cunha Cozac, Ana Paula Costa
    de Castro Figueiredo, Jose Fernando
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2007, 40 (06) : 678 - 680
  • [33] PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE
    Cazzagon, N.
    Boemo, D.
    Baldovin, T.
    Baldo, V.
    Egoue, J.
    Antoniazzi, S.
    Minola, E.
    Floreani, A.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S200 - S200
  • [34] Bone Marrow Toxicity in HCV Genotype 5a-Infected Patient after peg-IFN alpha-2a and Ribavirin Therapy
    Drapeau, C. M. J.
    Remotti, D.
    Noto, P.
    Capone, A.
    Boumis, E.
    Petrosillo, N.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 648 - 651
  • [35] SINGLE SERUM INTERFERON MEASUREMENT DURING THE FIRST WEEK OF CONTINUOUS INTERFERON ALPHA-2B WITH ORAL RIBAVIRIN PREDICTS RVR AND THERAPY DISCONTINUATION IN PATIENTS WITH CHRONIC HCV-1
    Lande, J.
    Grovender, E.
    Hamlen, C.
    Mische, S.
    Juth, S.
    Scherer, R.
    Van Antwerp, B.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S445 - S445
  • [36] COST-EFFECTIVENESS OF HEPATITIS C VIRUS (HCV) TREATMENT WITH TELAPREVIR/PEGYLATED INTERFERON ALPHA/RIBAVIRIN TRIPLE THERAPY VERSUS WAITING FOR NEW REGIMENS IN FRANCE
    Lee, A.
    Granados, D.
    Hulbert, E.
    McGarry, L.
    Fleischmann, J.
    VALUE IN HEALTH, 2013, 16 (07) : A497 - A497
  • [37] Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir
    Ishida, Hisashi
    Sakane, Sadatsugu
    Toyama, Takashi
    Fukutomi, Keisuke
    Kimura, Keiichi
    Sugimoto, Aya
    Hibino, Kenji
    Tamura, Takeshi
    Iwasaki, Tetsuya
    Iwasaki, Ryuichiro
    Hasegawa, Hiroko
    Sakakibara, Yuko
    Yamada, Takuya
    Nakazuru, Shoichi
    Mita, Eiji
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E84 - E91
  • [38] Viral kinetics of HCV genotype 4 during pegylated interferon alpha 2a-ribavirin therapy
    Derbala, Moutaz F.
    El Dweik, Nazeeh Z.
    Al Kaabi, Saad R.
    Al Marri, Ajayeb D.
    Bener, Abdel Bari
    Shebl, Fatma
    Amer, Aliaa M.
    Butt, Mohammed T.
    Yakoob, Rafie
    Al Mohanadi, Muneera
    Al Khinji, Mooza
    HEPATOLOGY, 2007, 46 (04) : 829A - 829A
  • [39] HBV RNA IN SERUM IS A PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING TREATMENT WITH PEG-INTERFERON ALPHA-2a (40KD)
    van Boemmel, F.
    van Boemmel, A.
    He, H.
    Wat, C.
    Deichsel, D.
    Berg, T.
    Boehm, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S442 - S443
  • [40] SERUM HBVRNA IS AN EARLY PREDICTOR OF HBeAg SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH PEG-INTERFERON ALPHA-2A (40kD)
    van Boemmel, F.
    van Boemmel, A.
    Krauel, A.
    He, H.
    Wat, C.
    Pavlovic, V.
    Deichsel, D.
    Berg, T.
    Boehm, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S560 - S561
12345